Ron Wald
About
Ron Wald is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Emergency Medicine.
According to data from OpenAlex, Ron Wald has authored 241 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Nephrology, 52 papers in Cardiology and Cardiovascular Medicine and 39 papers in Emergency Medicine. Recurrent topics in Ron Wald's work include Acute Kidney Injury Research (121 papers), Dialysis and Renal Disease Management (76 papers) and Chronic Kidney Disease and Diabetes (48 papers). Ron Wald is often cited by papers focused on Acute Kidney Injury Research (121 papers), Dialysis and Renal Disease Management (76 papers) and Chronic Kidney Disease and Diabetes (48 papers). Ron Wald collaborates with scholars based in Canada, United States and United Kingdom. Ron Wald's co-authors include Sean M. Bagshaw, Ziv Harel, Bertrand L. Jaber, Amit X. Garg, Glenn M. Chertow, Orfeas Liangos, Sushrut S. Waikar, Chaim M. Bell, Jeffrey Perl and Samuel A. Silver and has published in prestigious journals such as The Lancet, JAMA and Circulation.
In The Last Decade
Ron Wald
230 papers receiving 10.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ron Wald Canada | 55 | 7.0k | 2.1k | 2.0k | 1.8k | 1.8k | 241 | 10.9k | ||
| Bertrand L. Jaber United States | 52 | 6.9k 1.0× | 2.1k 1.0× | 2.1k 1.1× | 1.8k 1.0× | 1.2k 0.7× | 207 | 11.7k | ||
| Dinna N. Cruz Italy | 43 | 5.9k 0.8× | 1.8k 0.9× | 1.1k 0.6× | 1.9k 1.0× | 1.2k 0.7× | 156 | 8.8k | ||
| Paul M. Palevsky United States | 49 | 10.5k 1.5× | 3.3k 1.6× | 2.5k 1.3× | 3.0k 1.7× | 2.3k 1.3× | 205 | 15.8k | ||
| Kianoush Kashani United States | 50 | 3.8k 0.5× | 2.1k 1.0× | 1.2k 0.6× | 2.1k 1.1× | 1.8k 1.0× | 385 | 9.1k | ||
| Wilfred Druml Austria | 44 | 4.3k 0.6× | 2.0k 1.0× | 1.9k 1.0× | 1.4k 0.8× | 1.1k 0.6× | 183 | 8.2k | ||
| Michael Joannidis Austria | 51 | 4.2k 0.6× | 2.1k 1.0× | 2.5k 1.3× | 2.1k 1.2× | 974 0.5× | 256 | 9.9k | ||
| Eric A. J. Hoste Belgium | 62 | 6.8k 1.0× | 3.4k 1.6× | 2.0k 1.0× | 4.1k 2.3× | 1.1k 0.6× | 239 | 13.6k | ||
| Marlies Ostermann United Kingdom | 47 | 4.5k 0.6× | 2.3k 1.1× | 1.1k 0.6× | 2.1k 1.2× | 1.4k 0.8× | 271 | 8.4k | ||
| Lakhmir S. Chawla United States | 51 | 8.5k 1.2× | 2.7k 1.3× | 1.6k 0.8× | 2.7k 1.5× | 1.6k 0.9× | 176 | 12.8k | ||
| Michael Zappitelli Canada | 43 | 6.3k 0.9× | 1.7k 0.8× | 1.2k 0.6× | 1.7k 0.9× | 1.0k 0.6× | 154 | 8.2k |
Countries citing papers authored by Ron Wald
Since
Specialization
Citations
This map shows the geographic impact of Ron Wald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Wald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Wald more than expected).
Fields of papers citing papers by Ron Wald
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ron Wald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Wald. The network helps show where Ron Wald may publish in the future.
Co-authorship network of co-authors of Ron Wald
This figure shows the co-authorship network connecting the top 25 collaborators of Ron Wald. A scholar is included among the top collaborators of Ron Wald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Wald. Ron Wald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
See, Emily, et al.. (2025). The Impact of Sex on KRT in Acute Kidney Injury. Kidney360. 6(11). 1863–1872.
2.
Liu, Kathleen D., Jean‐Pierre Quenot, Azra Bihorac, et al.. (2025). Dialysis Dependence in Standard versus Accelerated Initiation of KRT in AKI. Clinical Journal of the American Society of Nephrology. 20(5). 601–607.
3.
Vaara, Suvi T., Ary Serpa Neto, Rinaldo Bellomo, et al.. (2024). Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis. Critical Care Explorations. 6(2). e1053–e1053.
4.
Beaubien–Souligny, William, Laurą Galarza, Vincent Lau, et al.. (2023). Prospective Study of Ultrasound Markers of Organ Congestion in Critically Ill Patients With Acute Kidney Injury. Kidney International Reports. 9(3). 694–702.
5.
Mathew, Roy O., David J. Maron, Rebecca Anthopolos, et al.. (2022). Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circulation Cardiovascular Quality and Outcomes. 15(10).
6.
Meraz-Muñoz, Alejandro, Nivethika Jeyakumar, Bin Luo, et al.. (2021). Cardiovascular Drug Use After AKI Among Hospitalized Patients with a History of Myocardial Infarction: A Population-Based Study. Journal of the American Society of Nephrology. 32(10S). 2–3.
7.
Garg, Amit X., Nadine Shehata, Shay McGuinness, et al.. (2018). Risk of Acute Kidney Injury in Patients Randomized to a Restrictive Versus Liberal Approach to Red Blood Cell Transfusion in Cardiac Surgery: A Substudy Protocol of the Transfusion Requirements in Cardiac Surgery III Noninferiority Trial. Canadian Journal of Kidney Health and Disease. 5. 2245628700–2245628700.
8.
Swaminathan, Madhav, Mark Stafford‐Smith, Glenn M. Chertow, et al.. (2017). Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery. Journal of the American Society of Nephrology. 29(1). 260–267.
9.
Massicotte‐Azarniouch, David, Anan Bader Eddeen, Amber O. Molnar, et al.. (2017). Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR. American Journal of Kidney Diseases. 70(6). 826–833.
10.
Acedillo, Rey, Ron Wald, Eric McArthur, et al.. (2017). Characteristics and Outcomes of Patients Discharged Home from an Emergency Department with AKI. Clinical Journal of the American Society of Nephrology. 12(8). 1215–1225.
11.
Walsh, Michael, Braden Manns, Amit X. Garg, et al.. (2015). The Safety of Eplerenone in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 10(9). 1602–1608.
12.
Hwang, Y. Joseph, Stephanie N. Dixon, Jeffrey P. Reiss, et al.. (2014). Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults. Annals of Internal Medicine.
13.
Wald, Ron, Salimah Z. Shariff, Neill K. J. Adhikari, et al.. (2013). The Association Between Renal Replacement Therapy Modality and Long-Term Outcomes Among Critically Ill Adults With Acute Kidney Injury. Critical Care Medicine. 42(4). 868–877.
14.
Gilbert, Cameron, Tara Gomes, Muhammad Mamdani, et al.. (2013). No Increase in Adverse Events During Aliskiren Use Among Ontario Patients Receiving Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers. Canadian Journal of Cardiology. 29(5). 586–591.
15.
James, Matthew T., Josée Bouchard, Julie Ho, et al.. (2013). Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury. American Journal of Kidney Diseases. 61(5). 673–685.
16.
Friedrich, Jan O., et al.. (2012). Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Critical Care. 16(4). R146–R146.
17.
Wald, Ron, Jan O. Friedrich, Sean M. Bagshaw, et al.. (2012). Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI) - a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Critical Care. 16(5). R205–R205.
18.
Kitchlu, Abhijat, Kristin K. Clemens, Tara Gomes, et al.. (2011). Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada. Nephrology Dialysis Transplantation. 27(4). 1591–1598.
19.
Friedrich, Jan O., et al.. (2010). High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Critical Care Medicine. 38(5). 1360–1369.
20.
Wong, Jason, Shaun G. Goodman, Raymond T. Yan, et al.. (2009). Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. European Heart Journal. 30(5). 549–557.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bertrand L. Jaber Breakdown of academic impact, for papers by Dinna N. Cruz Breakdown of academic impact, for papers by Paul M. Palevsky Breakdown of academic impact, for papers by Kianoush Kashani Breakdown of academic impact, for papers by Wilfred Druml Breakdown of academic impact, for papers by Michael Joannidis Breakdown of academic impact, for papers by Eric A. J. Hoste Breakdown of academic impact, for papers by Marlies Ostermann Breakdown of academic impact, for papers by Lakhmir S. Chawla Breakdown of academic impact, for papers by Michael Zappitelli